Human Metabolome Technologies, Inc.

6090.T
Diagnostics & Research
2026/10/30 18:57 Updated
Market Cap: $20.2M (¥3.2B)
Stock Price: $3.75 (¥591)
Exchange Rate: 1 USD = ¥157.48

Notice Regarding Disposal of Treasury Shares as Performance-Conditioned Post-Grant Restricted Stock Compensation

Announced completion of payment for disposal of treasury shares. Target shares: 9,982 shares of common stock; disposal price: 613 yen per share; total amount: 6,118,966 yen. Allocated to 2 directors; payment date was 2026-10-16.

Importance:
Page Updated: October 16, 2026
IR Disclosure Date: October 16, 2026

Key Figures

  • Number of treasury shares disposed: 9,982 shares
  • Disposal price: 613 yen/share
  • Total disposal amount: 6,118,966 yen

AI要約

Overview

Human Metabolome Technologies, Inc. announced that the payment procedures for the disposal of treasury shares as performance-conditioned post-grant restricted stock compensation have been completed. The shares disposed are 9,982 shares of the Company's common stock at 613 yen per share, totaling 6,118,966 yen. The shares were allocated to two directors. The payment date was 2026-10-16.

Impact and Outlook

This transaction is part of capital policy involving disposal of treasury shares and may have implications for shareholder returns and dilution. Specific subsequent procedures and use of funds are not described in the disclosed materials, but it indicates that the payment for the decided disposal of treasury shares has been completed.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Human Metabolome Technologies, Inc.

Company overview · Stock price · Financial data · All IR

View company page →